| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director, Chairman of Board of Directors | President and CEO
1 company
Patrick J McEnany is Director, Chairman of Board of Directors at CPRX. Patrick J McEnany's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider.
Our model assigns Patrick J McEnany a middling insider score of 60/100, based on 13 past trades. Over a 12-month horizon, 46.2% of those trades were profitable, with an average 12-month return of -2.2%.
Patrick J McEnany has 23 Form 4 filings on record from September 2022 to December 2025, all as Director, Chairman of Board of Directors at Catalyst Pharmaceuticals (CPRX), 2022–2025.
The 54 reported transactions were 21 option exercises, 14 open-market sales, 8 option or other derivative awards and 7 gifts, plus smaller numbers of other types.
Counted by filing, the open-market trades come to no purchases and 7 sales worth about $47.4M.
The largest open-market sale was 1,027,611 shares of CPRX at an average $15.41 on September 14, 2022, about $15.8M. Twelve months later CPRX was down 17%.
None of the 5 sales since April 2023 was marked as made under a Rule 10b5-1 trading plan.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 9, 2025 | CPRX Catalyst Pharmaceuticals, Inc. | Director, Chairman of Board of Directors | Sell | 200,000 | $26.09 | $5,217,338.42 | -4.5% | -22.3% | +21.3% | |
| Nov 20, 2024 | CPRX Catalyst Pharmaceuticals, Inc. | Director, Chairman of Board of Directors | Sale+OE | 170,845 | $21.23 | $3,627,258.86 | -3.7% | +8.4% | +7.7% | |
| Nov 14, 2024 | CPRX Catalyst Pharmaceuticals, Inc. | Director, Chairman of Board of Directors | Sale+OE | 137,155 | $22.58 | $3,096,800.56 | -3.0% | +4.7% | +6.9% | |
| Nov 12, 2024 | CPRX Catalyst Pharmaceuticals, Inc. | Director, Chairman of Board of Directors | Sale+OE | 492,000 | $23.39 | $11,510,102.00 | -9.9% | -1.2% | -1.1% | |
| May 15, 2023 | CPRX Catalyst Pharmaceuticals, Inc. | President and CEO | Sale+OE | 26,151 | $13.23 | $345,977.73 | -0.7% | +13.1% | +25.5% | |
| Nov 21, 2022 | CPRX Catalyst Pharmaceuticals, Inc. | President and CEO | Sale+OE | 500,000 | $15.54 | $7,767,500.00 | -11.4% | -2.0% | -11.7% | |
| Sep 14, 2022 | CPRX Catalyst Pharmaceuticals, Inc. | President and CEO | Sell | 1,027,611 | $15.41 | $15,832,730.93 | -20.8% | +14.7% | -17.5% |